The Impacts of Breakthrough Drug Classes on Total Healthcare Expenditures
**Background:** Pharmaceutical firms spend billions of dollars developing new therapies, which are often sold at a substantial premium over older therapies. The costs and benefits of these newer and more expensive drugs, however, are controversial. The empirical evidence on whether newer drugs can d...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Columbia Data Analytics, LLC
2016-02-01
|
| Series: | Journal of Health Economics and Outcomes Research |
| Online Access: | https://jheor.org/article/9873-the-impacts-of-breakthrough-drug-classes-on-total-healthcare-expenditures |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|